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Abstract
Background Whole-bodyMRI is used for staging paediatric Hodgkin lymphoma, commonly using size thresholds, which fail to
detect disease in normal-size lymph nodes.
Objective To investigate quantitative whole-body MRI metrics for nodal characterisation.
Materials and methods Thirty-seven children with Hodgkin lymphoma underwent 1.5-tesla (T) whole-bodyMRI using short tau
inversion recovery (STIR) half-Fourier-acquisition single-shot turbo-spin-echo and diffusion-weighted imaging
(DWI). 18Flourine-2-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET)/CT was acquired as the
reference standard. Two independent readers assessed 11 nodal sites. The readers measured short-axis-diameter,
apparent diffusion coefficient, (ADC) and normalised T2-signal intensity of the largest lymph node at each site.
We used receiver operating characteristics (ROC)/area-under-the-curve (AUC) analysis for each MRI metric and
derived sensitivity and specificity for nodes with short-axis diameter ≥10 mm. Sub-analysis of sensitivity and
specificity was performed with application of ADC cut-off values (<0.77, <1.15 and <1.79×10−3 mm2 s−1) to 5-
to 9-mm nodes.
Results ROC/AUC values for reader 1/reader 2 were 0.80/0.80 and 0.81/0.81 for short-axis-diameter measured using DWI and
STIR half-Fourier-acquisition single-shot turbo spin echo, respectively; 0.67/0.72 for normalised T2 signal intensity
and 0.74/0.67 for ADC. Sensitivity and specificity for a short-axis diameter ≥10 mm were 84.2% and 66.7% for
Reader 1 and 82.9% and 68.9% for Reader 2. Applying a short-axis-diameter ≥10-mm threshold followed by ADC
cut-offs to normal-size 5- to 9-mm nodes resulted in sensitivity and specificity for Reader 1 of 88.8% and 60%,
92.1% and 56.7%, and 100% and 16.7%; and for Reader 2, 86.1% and 67.2%, 95.3% and 65.6%, and 100% and
19.7%; and ADC thresholds of <0.77, <1.15, and <1.79×10−3 mm2 s−1, respectively.
Conclusion Nodal size measurement provides the best single classifier for nodal disease status in paediatric Hodgkin
lymphoma. Combined short-axis diameter and ADC thresholds marginally improve sensitivity and drop specificity compared with
size classification alone.
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Introduction
18Flourine-2-fluoro-2-deoxyglucose (FDG) positron emission
tomography (PET) fused with CT scan (FDG PET/CT), per-
formed on a hybrid system, has become the gold standard
modality for evaluating lymphoma including Hodgkin
lymphoma, with proven improvement at staging and
follow-up monitoring compared with either CT or FDG
PET alone [1, 2]. However, FDG PET/CT imparts a con-
siderable dose of ionising radiation, which is of particular
concern within the paediatric population [3]. Even with
low-dose protocols, paediatric patients undergoing a sin-
gle FDG PET/CT examination are exposed to ionising
radiation on the order of 10–20 mSv [4], equivalent to
700–750 chest radiographs. Compared with an adult older
than 30 years, exposure to ionising radiation in early
childhood causes roughly a tripling in lifetime cancer risk
by comparison [5]. Children are inherently more radiosen-
sitive than adults and exposure to ionising radiation is
more likely to increase the risk of secondary malignancies
(radiation-induced malignancies) in children because of
their smaller body size, repeated studies to assess treat-
ment response or relapse, and longer survival following
treatment [6, 7]. In paediatric and young adults with
Hodgkin lymphoma, more than 90% of patients survive
10 years [8], and hence radiation-induced mortality and
risk of developing secondary cancers are of more concern
in children and adolescents with Hodgkin lymphoma.
Whole-body MRI provides a radiation-free alternative
for the staging of paediatric lymphoma [9, 10]. Yet, sim-
ilar to CT, nodal classification remains dependent pre-
dominantly on size measurement, with image contrast used
to help localise nodes [11]. Diffusion-weighted imaging
(DWI)-derived apparent diffusion coefficient (ADC) has been
reported as a potential imaging biomarker for evaluating treat-
ment response in lymphoma [12, 13]. Several studies have
suggested that ADC values for malignant lymph nodes are
lower compared with benign lymph nodes [14, 15].
However, little has been reported on combining the quantita-
tive parameters provided by sequences such as DWI with
standard size measurement to determine whether this provides
improved diagnostic accuracy for nodal disease classification
[16]. The aim of this study was to determine the potential
added diagnostic value of quantitative parameters derived
fromwhole-bodyMRI for classifying lymph nodes in children
and adolescents with Hodgkin lymphoma compared to the
FDG PET/CT reference standard.
Materials and methods
Our institutional review board approved the study and
waived the requirement for individual patient consent
for use of anonymous clinical and research patient
datasets (R&D No: 12/0195 date:16/06/2012).
Data collection
We reviewed our institutional database for patients referred
with suspected Hodgkin lymphoma to the paediatric
haemato-oncology clinic. The period between 2009 and
2012 (during which whole-body MRI was part of standard
clinical practice at our institution) was interrogated using the
following inclusion criteria: (1) confirmed Hodgkin lympho-
ma on biopsy, (2) age ≤18 years, (3) full whole-body MRI
dataset at baseline (below), and (4) FDG PET/CT performed
contemporaneously to whole-body MRI. Exclusion criteria
were: (1) prior treatment for malignancy other than Hodgkin
lymphoma, (2) restaging as part of relapsed Hodgkin lympho-
ma assessment and (3) incomplete whole-body MRI dataset.
Patients were followed with both whole-body MRI and FDG
PET/CT for a minimum of 2 years following completion of
chemotherapy.
Whole-body magnetic resonance imaging protocol
Imaging was performed on a 1.5-tesla (T) scanner
(Avanto; Siemens, Erlangen, Germany), with the manu-
facturers’ body- and spine-array coils and the patient in
supine position. Immediately prior to imaging, 0.3 mg/kg
of body weight of intravenous hyoscine butylbromide
(Buscopan; Boehringer Ingelheim, Ingelheim, Germany)
was administered. The complete whole-body MRI study
comprised respiratory and electrocardiographically gated
axial and coronal whole-body short tau inversion recov-
ery (STIR) half-Fourier acquisition single-shot turbo
spin echo and whole-body DWI of neck, chest, abdo-
men and pelvis, complemented by multi-phase dynamic
contrast-enhanced imaging of the liver and spleen and
breath-held periodically rotated overlapping parallel
lines with enhanced reconstruction imaging of the lungs
and mediastinum. Diffusion-weighted imaging was per-
formed in the axial plane during free breathing using a
STIR echoplanar imaging sequence with diffusion gra-
dients applied in three orthogonal directions at b values
of 0 s/mm2, 300 s/mm2 and 500 s/mm2 and calculation
of trace-weighted images. A single dose (0.1 mmol/kg)
of intravenous gadoterate meglumine (Dotarem;
Laboratoire Guerbet, Aulnay-sous-Bois, France) was
injected at 3 mL/s, followed by 10 mL of saline flush.
At the start of injection, the child was requested to
breath-hold for 30 s during rapid dynamic T1-weighted
MRI using a 3-D fast low-angle-shot technique. Eighty
contiguous 2.5-mm-thick axial images covering the en-
tire liver and spleen were acquired every 5 s. Imaging
was then paused for 10 s to al low control led
1286 Pediatr Radiol (2019) 49:1285–1298
(instructed) breathing, then two further 5-s acquisitions
were performed during a 10-s breath hold, followed by
a further 10-s pause for breathing. Interleaved imaging
and breath holds were continued for a total of 2 min
from the start of intravenous injection. Finally, a multi-
breath-holds periodically rotated overlapping parallel
lines with enhanced reconstruction MRI was used to
acquire images at maximum inspiration to separate the
mediastinum from the chest wall and to provide dedi-
cated lung imaging. Twenty-three axial images were ac-
quired with a 3-mm slice thickness during each breath
hold. Stacks were repeated to cover the entire chest.
The entire protocol was completed in an average of an
hour. Full sequence parameters are detailed in Table 1.
18Flourine-2-fluoro-2-deoxyglucose (FDG) positron
emission tomography (PET)/CT protocol
FDG PET/CT scans were acquired using a dedicated com-
bined PET/CT in-line system (Discovery LS; GE
Healthcare, Milwaukee, WI). Patients fasted for 6 h prior to
scanning, and blood glucose levels were checked to exclude
hyperglycaemia (>150 mg/dL). For paediatric patients, the
doses were adjusted according to the European Association
of Nuclear Medicine paediatric dosage card [17]. 18Flourine -
FDG (14–370MBq)was intravenously injected 60min before
imaging. Prior to acquiring the whole-body PET 3-D emission
scan, a non-contrast CT was obtained for attenuation correc-
tion (80–120 kVp, modulated mA [10–200 mA], pitch 1.375,
3.75-mm slice thickness). Images were acquired at 3 min per
bed position as per departmental paediatric protocol.
18Flourine-2-fluoro-2-deoxyglucose (FDG) positron
emission tomography (PET)/CT image analysis
FDG PET/CT images were assessed in consensus by
two radionuclide radiologists (L.J.M. and A.H., with 7
and 5 years of experience, respectively). All images
were assessed using advanced PET/CT review software
(Advantage, version 4.2; GE Medical Systems) with in-
built capability to scroll through the corresponding PET,
CT and fused images in transverse, coronal and sagittal
planes and the maximum-intensity projection images.
Disease positivity within lymph nodes was defined as
the presence of FDG uptake greater than that of the
background physiological activity in a clinically suspi-
cious node, or CT short-axis diameter ≥10 mm. The
FDG PET/CT positivity/negativity was used as the ref-
erence standard against which whole-body MRI was
assessed.
Whole-body magnetic resonance imaging analysis
Whole-body MRI datasets were analysed using Osirix
(version 4.1; Pixmeo SARL, Bernex, Switzerland) on a
Mac (Apple, Cupertino, CA) workstation. Two radiolo-
gists (S.P. and P.D.H., each with more than 10 years of
experience with MRI) independently reviewed the
whole-body MRI studies blinded to clinical data and
FDG PET/CT results. Nodal involvement was assessed
in 11 nodal stations (i.e. cervical, supraclavicular, sub-
pectoral, axillary, mediastinal, splenic hilar, liver hilar,
mesenteric, retroperitoneal, iliac and inguinal regions).
The maximum short-axis diameter of the largest nodal
























800/60 800/60 4,900/66 3,000/133 2.87/0.93
Inversion time (ms) 130 130 180 N/A N/A
Matrix 256×256 256×256 128×96 256×256 256×176
Slice thickness (mm) 7 7 4 3 2.5
No. of slices 19 27 27 23 80
Stacks 6–8 2 6–8 2–4 1
Averages 2 2 8 1 1
Echo train 256 256 1 50 1
Flip angle (degrees) 180 180 90 150 9
Parallel acquisition 2 2 2 1 2
STIR short tau inversion recovery
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mass in a given region on axial STIR half-Fourier-
acquisition single-shot turbo-spin-echo and DWI whole-
body MRI was measured using software calipers.
Disease positivity was defined as a nodal mass with
short-axis diameter ≥10 mm. Each of the two original
reporting radiologists independently extracted quantita-
tive parameters from the whole-body MRI dataset.
Each radiologist selected and marked the largest lymph
node (short-axis diameter ≥5 mm) in each nodal station,
and recorded the measured size on both axial STIR
half-Fourier-acquisition single-shot turbo-spin-echo and
b=500 s/mm2 diffusion-weighted imaging. We excluded
from analysis sites where all nodes were <5 mm in
short-axis diameter, to minimise partial volume errors
effecting extracted quantitative metrics. For ADC extrac-
tion: a region of interest was manually contoured on
b=500 s/mm2 images and then copied and pasted to
subsequent b=300 s/mm2 and b=0 s/mm2 images. The
average signal intensity of the regions of interest (size
range 29–763 mm2) was calculated at each b value and
ADC derived by least squares fit to the signal intensity
versus b value plotted [12]. For normalised T2 signal
intensity extraction: a region of interest was carefully
contoured on axial STIR half-Fourier-acquisition
single-shot turbo-spin-echo images and the average
region-of-interest signal intensity (size range 22–
812 mm2) was normalised against right obturator
internus muscle signal intensity [18].
18Flourine-2-fluoro-2-deoxyglucose (FDG) positron
emission tomography (PET)/CT and whole-body MRI
anatomical matching
Anonymised whole-body MRI and FDG PET/CT
datasets were assessed in consensus by two reporting
radiologists, a radionuclide radiologist and a paediatric
haemato-oncologist. Lymph nodes were visually
matched between whole-body MRI and FDG PET/CT,
with the node selected for whole-body MRI quantitative
analysis localised on the reference standard against FDG
PET/CT to confirm reference standard positivity/
negativity.
Statistical analysis
All statistical analyses were performed using Prism (version
5.0; GraphPad Software, San Diego, CA). Distribution nor-
mality was assessed by the Kolmogorov–Smirnov test.
The Mann–Whitney test was used to assess difference
of median ADC and normalised T2 signal intensity
among (a) FDG PET/CT positive and negative lymph
nodes with short-axis diameter ≥5 mm, (b) FDG PET/
CT positive and negative nodes with 5- to 9-mm short-
axis diameter, and (c) 5- to 9-mm short-axis diameter
nodes and short-axis diameter ≥10-mm nodes.
Interobserver (reader 1 vs. reader 2) and inter-sequence
(STIR half-Fourier acquisition single-shot turbo spin
echo vs. diffusion-weighted imaging) agreement of nod-
al size measurement as well as interobserver agreement
for ADC and normalised T2 signal intensity were deter-
mined by Bland-Altman method [19].
We calculated ROC/AUC for classification of nodes
(against the FDG PET/CT reference standard) for each
reader for each quantitative parameter (DWI size, T2
size, normalised T2 signal intensity and ADC). The sen-
sitivity and specificity for whole-body MRI nodal clas-
sification (for all nodes ≥5 mm) based on a size criteria
short-axis diameter threshold of ≥10 mm indicating pos-
itivity were calculated for individual readers against the
reference standard FDG PET/CT. We applied previously
published ADC cut-off values (0.77, 1.15 and 1.79
×10−3 mm2 s−1 corresponding to median (1.15×10−3
mm2 s−1 ), minimum (0.77×10−3 mm2 s−1 ) and maxi-
mum (1.79×10−3 mm2 s−1 ) ADC values for FDG PET/
CT positive nodes) to determine classification perfor-
mance for 5- to 9-mm “normal sized” lymph nodes.
[20].
A short-axis diameter threshold of ≥10 mm was ini-
tially applied to all measured nodes, determining nodes
≥10 mm as positive. This was followed by application
of ADC cut-offs to 5- to 9-mm short-axis diameter
normal-size lymph nodes, ascribing nodes with ADC
values below the threshold as positive. Sensitivity and
specificity for nodal involvement based on combined
short-axis diameter and apparent diffusion coefficient
classification were determined for each of the three
ADC thresholds.
Results
Thirty-seven children and young adults (male/female:
16/21; mean age 16.1 years; range 12.8–18 years) all
had required baseline and follow-up whole-body MRI
sequences and were therefore eligible for inclusion in
the study. Staging whole-body MRI was performed
within a median of 3 days (range 0–19 days) of FDG
PET/CT, without any complications and before treat-
ment in all patients. Across the cohort, 3 children had
Stage I, 11 had Stage II, 2 had Stage IIE, 8 had Stage
III and 13 had stage IV disease. One hundred fifty-two
nodal sites were positive on reference standard FDG
PET/CT. Eighteen and 23 nodes were 5- to 9-mm
short-axis diameter and positive according to reference
standard FDG PET/CT for Reader 1 and Reader 2,
respectively.
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Based on the Kolmogorov–Smirnov test, both ADC
and normalised T2-signal-intensity metrics were not nor-
mally distributed. Median ADC and normalised T2
signal intensity for FDG PET/CT-positive and FDG
PET/CT-negative lymph nodes are shown in Fig. 1
and Table 2 for both radiologists. For lymph nodes with
5- to 9-mm short-axis diameter, median ADC was sig-
nificantly lower (P<0.0001) for FDG PET/CT-positive
compared with FDG PET/CT-negative lymph nodes,
whilst there was no significant difference in median
normalised T2 signal intensity (Fig. 2, Table 2).
Median ADC was significantly higher and median nor-
malised T2 signal intensity significantly lower in nodes
with 5- to 9-mm short-axis diameter compared with
nodes with ≥10-mm short-axis-diameter (Fig. 3 and
Table 2). Bland-Altman plots for interobserver and
inter-sequence size measurement agreements (DWI
b=500 s/mm2 and STIR half-Fourier-acquisition single-
shot turbo spin echo) are shown in Fig. 4. Bland-
Altman plots of interobserver agreements for ADC and
normalised T2 signal intensity measurements are repre-
sented in Fig. 5.
Fig. 1 Box plots compare apparent diffusion coefficient (ADC) and
normalised T2 signal intensity according to 18flourine-2-fluoro-2-
deoxyglucose (FDG) positron emission tomography (PET)/CT
positivity/negativity criteria for all nodes measuring 5 mm on whole-
body MRI. Boxes represent 25th and 75th percentiles and the lines in
the middle of the boxes represent the median values. Whiskers represent
10th and 90th percentiles and dots represent outliers. a Comparison of
ADC measurements between FDG PET/CT-positive and -negative nodes
for Reader 1 shows significantly lower values for FDG PET/CT-positive
nodes compared to FDG PET/CT-negative nodes. b Comparison of ADC
measurements between FDG PET/CT-positive and -negative nodes for
Reader 2 shows significantly lower values for FDG PET/CT-positive
nodes compared to FDG PET/CT-negative nodes. c Comparison of
Normalised T2 signal intensity measurements between FDG PET/CT-
positive and -negative nodes for Reader 1 shows significantly higher
values for FDG PET/CT-positive nodes compared to FDG PET/CT-
negative nodes. d Comparison of normalised T2 signal intensity
measurements between FDG PET/CT-positive and -negative nodes for
Reader 2 shows significantly higher values for FDG PET/CT-positive
nodes compared to FDG PET/CT-negative nodes. Results are tabulated
in Table 2. a.u. arbitrary unit
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Receiver operating characteristic/area
under the curve analysis (all nodes)
ROC/AUC graphs are presented in Fig. 6. For Reader 1, the
AUCs for nodal size measurement on b=500 s/mm2 DWI and
for STIR half-Fourier-acquisition single-shot turbo spin echo
were 0.80 (95% confidence interval [CI] = 0.73–0.87) and
0.81 (95% CI=0.75–0.88), respectively. For Reader 2, the
AUCs for nodal size measurement on b=500 s/mm2 DWI
and for STIR half-Fourier acquisition single-shot turbo spin
echo were 0.80 (95%CI=0.73–0.87) and 0.81 (95%CI=0.74–
0.87), respectively. The AUCs for the apparent diffusion
coefficient and for the normalised T2 signal intensity for
Reader 1 were 0.74 (95% CI=0.67–0.82) and 0.66 (95%
CI=0.58–0.74), respectively. For Reader 2 the ADC and the
normalised T2 signal intensity AUCs were 0.67 (95%
CI=0.59–0.75) and 0.72 (95% CI=0.64–0.79), respectively.
Short-axis-diameter threshold-based
sensitivity/specificity (all nodes)
The sensitivity and specificity for short-axis-diameter ≥10-
mm size threshold as applied to all lymph nodes were 84.2%
and 66.7% for Reader 1 and 82.9% and 68.9% for Reader 2.
Fig. 2 Box plots compare apparent diffusion coefficient (ADC) and
normalised T2 signal intensity for nodes measuring 5–9 mm according
to 18flourine-2-fluoro-2-deoxyglucose (FDG) positron emission
tomography (PET)/CT positivity/negativity. Boxes represent 25th and
75th percentiles and the lines in the middle of the boxes represent the
median values. Whiskers represent 10th and 90th percentiles and dots
represent outliers. a Comparison of ADC measurements for 5- to 9-mm
nodes for Reader 1 show significantly lower values for FDG PET/CT-
positive nodes compared to FDG PET/CT-negative nodes. b Comparison
of ADC measurements for 5- to 9-mm nodes for Reader 2 shows
significantly lower values for FDG PET/CT-positive nodes compared to
FDG PET/CT-negative nodes. c Comparison of Normalised T2 signal
intensity measurements for 5- to 9-mm nodes for Reader 1 shows no
significant difference for FDG PET/CT-positive nodes compared to
FDG PET/CT-negative nodes. d Comparison of Normalised T2 signal
intensity measurements for 5- to 9-mm nodes for Reader 2 shows no
significant difference for FDG PET/CT-positive nodes compared to
FDG PET/CT-negative nodes. Results are tabulated in Table 2. a.u.
arbitrary unit
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Apparent diffusion coefficient threshold
sensitivity/specificity (for nodes 5–9 mm)
The sensitivity and specificity for the ADC cut-off values of
0.77, 1.15 and 1.79×10−3 mm2 s−1 as applied to 5- to 9-mm
short-axis-diameter lymph nodes is tabulated in Table 3.
Combined short-axis-diameter and apparent diffusion
coefficient thresholds sensitivity/specificity (all
nodes)
The sensitivity and specificity of combining short-axis-
diameter ≥10-mm size threshold applied to all nodes,
followed by ADC cut-off values of 0.77, 1.15 and
1.79×10−3 mm2 s−1 to 5- to 9-mm lymph nodes for both
readers, are given in Table 4. Figures 7 and 8 demonstrate
examples of true-positive and false-positive whole-body
MRI nodal classification using the combined short-axis
diameter and ADC threshold.
Discussion
Whole-body MRI is being increasingly advocated as an
alternative or adjunct to FDG PET/CT for staging and
response monitoring in paediatric lymphoma. Previously
published works have shown that morphological MRI
and DWI can be implemented in whole-body MRI pro-
tocols for assessing the extent of disease [9, 13]. MRI
signal itself can be made sensitive to the presence of
Fig. 3 Box plots compare apparent diffusion coefficient (ADC) and
normalised T2 signal intensity according to nodal short-axis-diameter
measurements. Boxes represent 25th and 75th percentiles and the lines
in the middle of the boxes represent the median values. Whiskers
represent 10th and 90th percentiles and dots represent outliers. a
Comparison of ADC measurements for Reader 1 shows significant
difference between nodes measuring 5–9 mm and nodes measuring
Size >10 mm. b Comparison of ADC measurements for Reader 2
shows significant difference between nodes measuring 5–9 mm and
nodes measuring Size >10 mm. c Comparison of Normalised T2 signal
intensity measurements for Reader 1 shows significant difference
between nodes measuring 5–9 mm and nodes measuring Size >10 mm.
d Comparison of Normalised T2 signal intensity measurements for
Reader 2 shows significant difference between nodes measuring 5–
9 mm and nodes measuring Size >10 mm. Results are tabulated in
Table 2. a.u. arbitrary unit
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Fig. 4 Bland-Altman plots for
inter-sequence (axial short tau
inversion recovery [STIR] half-
Fourier-acquisition single-shot
turbo spin echo vs. axial
diffusion-weighted imaging
[DWI; b=500 s/mm2] and
interobserver (Reader 1 vs.
Reader 2) agreements for nodal
size measurement. Bias (solid
line) and 95% limits of agreement
(dashed lines) indicated. a For
Reader 1, there was a bias of
0.020 cm and 95% limits of
agreement of−0.59 to +0.63. b
For Reader 2, there was a bias of
−0.010 cm and 95% limits of
agreement of−0.52 to +0.50 for
inter-sequence size measurement
agreements. c Short-axis nodal
size measurements on axial STIR
half-Fourier-acquisition single-
shot turbo spin echo exhibit a bias
of 0.017 cm and 95% limits of
agreement of−0.55 to +0.58
between the two readers. d Short-
axis nodal size measurements on
axial DWI (b=500) exhibit a bias
of 0.038 cm and 95% limits of
agreement of−0.55 to +0.63
between the two readers
Fig. 5 Bland-Altman plots for interobserver (Reader 1 vs. Reader 2)
agreement of apparent diffusion coefficient (ADC) and normalised T2-
signal-intensity measurements for lymph nodes with short-axis diameter
≥5 mm. Bias (solid line) and 95% limits of agreement (dashed lines)
indicated. a ADC measurements exhibit a bias of 0.03×10−3 mm2 s−1
and 95% level of agreement of−0.52 to +0.58. b Normalised T2 signal
intensity measurements show a bias of 0.04 (a.u.) and 95% level of
agreement of−1.16 to +1.25. a.u. arbitrary unit
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pathology, and as such, MRI offers the opportunity to
use signal characteristics as well as morphological fea-
tures to classify disease.
Size measurement is conventionally used to determine
nodal positivity. We investigated whether the performance
of whole-body MRI for nodal classification, based on size
measurement, was different when measurements were
made on whole-body DWI rather than anatomical whole-
body STIR half-Fourier-acquisition single-shot turbo-
spin-echo imaging. We found that measurements made
on either sequence yielded a comparable diagnostic accu-
racy for detecting involved lymph nodes and that size
measurement provides the best classifier for nodal disease
status.
In our study, diseased lymph nodes had significantly
lower ADC values than benign lymph nodes (as highlight-
ed by the FDG PET/CT reference standard); this finding
supported the results of prior investigators [21, 22]. For
instance, Perrone et al. [23] demonstrated that the mean
ADC value for malignant cervical lymph nodes was sig-
nificantly lower than that of benign lymphadenopathy
(0.85×10−3 mm2 s−1 and 1.44×10−3 mm2 s−1, respectively,
P<0.01). In another study, the authors showed that com-
pared to benign lymphadenopathy and metastatic lymph-
adenopathy from head and neck cancers, lymphomatous
lymph nodes had a significantly lower mean ADC value
[21]. Whilst our results demonstrate good classification by
ADC value (ROC/AUC of 0.67–0.74), we note that the
performance of the ADC was not greater than simply
measuring nodal size (ROC/AUC 0.80–0.81).
We also noticed that for nodes deemed negative for
disease based on size criteria (measuring 5–9 mm) there
was significant difference in ADC between disease-
positive and disease-negative nodes (P<0.0001). It is
Fig. 6 Receiver operating characteristic (ROC)/area under the curve
(AUC) analysis for classification of nodes for each quantitative
parameter measurement made by (a) Reader 1, and (b) Reader 2. Size
measurements on diffusion-weighted imaging (DWI) and short tau
inversion recovery (STIR) half-Fourier-acquisition single-shot turbo-
spin-echo images achieved the highest AUC for both readers: 0.80,
95% confidence interval [CI] = 0.73–0.87, and 0.81, 95% CI=0.75–
0.88 for Reader 1; and 0.80, 95% CI=0.73–0.87, and 0.81, 95%
CI=0.74–0.87 for Reader 2, respectively. ROC/AUC for the apparent
diffusion coefficient was 0.74 (95% CI=0.67–0.82) and 0.67 (95%
CI=0.59–0.75) for Readers 1 and 2, respectively. ROC/AUC for
normalised T2 signal intensity was 0.66 (95% CI=0.58–0.74) and 0.72
(95% CI=0.64–0.79) for Readers 1 and 2, respectively
Table 4 Sensitivity and specificity of combined short-axis-diameter
≥10-mm size threshold applied to all nodes, followed by apparent
diffusion coefficient (ADC) cut-off values applied to 5- to 9-mm short-
axis-diameter lymph nodes
Sensitivity Specificity
ADC values Reader 1 Reader 2 Reader 1 Reader 2
0.77×10−3 mm2 s−1 88.8% 86.1% 60.0% 67.2%
1.15×10−3 mm2 s−1 92.1% 95.3% 56.7% 65.6%
1.79×10−3 mm2 s−1 100% 100% 16.7% 19.7%
Table 3 Sensitivity and specificity of apparent diffusion coefficient
(ADC) for classification of disease in 5- to 9-mm short-axis-diameter
lymph nodes
Sensitivity Specificity
ADC values Reader 1 Reader 2 Reader 1 Reader 2
0.77×10−3 mm2 s−1 5.6% 8.7% 100% 100%
1.15×10−3 mm2 s−1 33.3% 63.6% 92% 94.4%
1.79×10−3 mm2 s−1 100% 92% 24% 35.3%
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not surprising, therefore, that after applying ADC cut-off
values [20] to 5- to 9-mm lymph nodes, there was an
overall increase in whole-body DWI’s sensitivity for both
readers. However, the increase in whole-body DWI’s
sensitivity came at the expense of noticeable decrease
in specificity. We conclude that early nodal involvement
(where size remains <1 cm) cannot be reliably classified
using DWI and hypothesise that this likely reflects insuf-
ficient increase in cellularity to significantly alter water
diffusion [24].
Our result for interobserver reproducibility of ADC
measurements for lymph nodes in children and adoles-
cents with Hodgkin lymphoma emulates previous find-
ings for nodal ADC reproducibility in healthy volun-
teers [25, 26]. Moreau et al. [26] found that the inter-
reader reproducibility for their ADC measurements
showed an absolute bias of 0.045×10−3 mm2 s−1 (level
of agreement −0.146; 0.056). Although both studies
used a different protocol compared to our study, they
highlighted that ADC measurement in healthy volun-
teers might not always be adequately reproducible and
that a reliable use of ADC values requires further tech-
nical advances and systematic quality control [25, 26].
Short tau inversion recovery half-Fourier-acquisition
single-shot turbo-spin-echo images generate contrast to
highlight water whilst nulling signal from fat [27]. In
theory, replacement of the normal fatty hilum by
cellular infiltrate as occurs in pathology should increase
the STIR half-Fourier-acquisition single-shot turbo-spin-
echo signal from diseased lymph nodes [28]. This was
reflected in our results, with FDG PET/CT-positive
lymph nodes demonstrating approximately 20% in-
creased signal on STIR half-Fourier-acquisition single-
shot turbo-spin-echo images compared to FDG PET/
CT-negative nodes. As a univariate classification param-
eter, normalised T2 signal-intensity classification perfor-
mance (ROC/AUC 0.66–0.72) was not as high as ADC
or nodal size measurement parameters.
Ohno et al. [29] evaluated 135 metastatic and 135
non-metastatic mediastinal and hilar lymph nodes in
their cohort of 93 patients with N1-N3 non-small-cell
lung cancer using 1.5-T STIR turbo-spin-echo MRI,
diffusion-weighted imaging and FDG PET/CT, with the
reference standard being histopathological samples. In
line with our results, they showed that lymph node sig-
nal intensity as normalised to muscle signal intensity
(lymph-node-to-muscle ratio) on STIR turbo-spin-echo
sequence was significantly higher in metastatic lymph
nodes compared to non-metastatic lymph nodes (mean
lymph-node-to-muscle ratio 1.5 ± 0.3 [range 0.6–2.2]
and 1.0 ± 0.3 [range 0.4–1.8] for metastatic and non-
metastatic lymph nodes, respectively, P<0.0001).
However contrary to our results, the performance of
lymph-node-to-muscle ratio for determining metastatic
Fig. 7 Images in a 15-year-old boy with Hodgkin lymphoma. a Axial
18flourine-2-fluoro-2-deoxyglucose (FDG) positron emission
tomography (PET)/CT shows a positive left axillary node (arrow). b
Axial short tau inversion recovery half-Fourier acquisition single-shot
turbo-spin-echo (repetition time/echo time [TR/TE] = 800/60 ms) MR
image demonstrates an 8-mm short-axis-diameter left axillary node
(arrow). c Axial diffusion-weighted imaging (DWI; b=500 s/mm2; TR/
TE=4,900/66 ms) demonstrates an 8-mm short-axis-diameter left axillary
node. These findings would result in false-negative nodal classification
according to the threshold of short-axis diameter ≥10 mm. d Apparent
diffusion coefficient (ADC) map demonstrates the same left axillary node
(arrow) with an ADC of 0.8×10−3 mm2 s−1. The node was deemed
positive on whole-body MRI using the combined short-axis diameter
≥10 mm and ADC cut-off of <1.15×10−3 mm2 s−1 classification — a
true-positive result compared with using the FDG PET/CT reference
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lymph nodes was higher than that of ADC values in
their cohort. This might be caused by two major differ-
ences between the two studies: first, the underlying ma-
lignancies were different between the two cohorts; sec-
ond, Ohno et al. [29] only investigated mediastinal and
hilar lymph nodes whilst we included all the measurable
nodal stations above and below the diaphragm.
In our study, we included the nodal stations comprising
only measurable nodes with short-axis diameter ≥5 mm, for
two reasons. First, quantitative analysis of small nodes is more
likely to be affected by partial volume errors compared with
larger nodes. Second, and more important, almost all <5-mm
lymph nodes in paediatric patients with Hodgkin lymphoma
are negative on FDG PET/CT (indeed, we did not find a single
FDG PET/CT-positive node in our cohort) and do not present
a diagnostic challenge. Application of quantitative metrics
should be for nodes in which there might be a diagnostic
dilemma. Studies that include large numbers of nodes
<5 mm within their population are likely to demonstrate arti-
ficially high levels of specificity for the technique being
assessed.
Our results have direct clinical implications. They suggest
that ADC values should not be used as a discriminator of nodal
disease status in children with lymphoma and confirm the dom-
inance of nodal size as the best classifier of disease status.
Furthermore, if diffusion weighted imaging is used for staging
paediatric lymphoma, it is sufficient to make measurements of
nodal size directly from diffusion-weighted images (b=500 s/
mm2) rather than from anatomical imaging such as STIR half-
Fourier-acquisition single-shot turbo-spin-echo images. This
might help to reduce scan times by providing an opportunity
to replace STIR half-Fourier-acquisition single-shot turbo spin
echo with a faster anatomical acquisition such as modified
DIXON imaging [30, 31] or obviating the requirement for
Fig. 8 Images in a 16-year-old




is deemed negative for left
cervical nodal involvement. b
Axial short tau inversion recovery
half-Fourier-acquisition single-
shot turbo-spin-echo (repetition
time/echo time [TR/TE] = 800/
60 ms) MR image demonstrates a
5-mm short-axis-diameter left
cervical node (arrow). c Axial
diffusion-weighted imaging
(DWI; b=500 s/mm2; TR/
TE=4,900/66 ms) demonstrates a
5-mm short-axis-diameter left
cervical node (arrow). These
findings would result in true-
negative nodal classification. d
Apparent diffusion coefficient
(ADC) map demonstrates the
same left cervical node (arrow)
with ADC of 0.9×10−3 mm2 s−1.
The node was deemed positive on
whole-body MRI by combined
short-axis diameter ≥10 mm and
ADC cut-off value of
<1.15×10−3 mm2 s−1
classification — a false-positive
result compared with using the
FDG PET/CT reference
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DWI based on no additional classification value. Limiting over-
all scan time is particularly important for paediatric patients and
has direct heath care cost implications.
There were limitations to our study. First, we did not have
histopathological confirmation for positivity/negativity for
nodal involvement by lymphoma. We used FDG PET/CT as
the reference standard because this is the current gold standard
modality of imaging with excellent performance [32]. We
have assumed that discordances between whole-body MRI
and the FDG PET/CT reference are related to limitations in
sensitivity/specificity of the whole-body MRI technique, but
we acknowledge that a small number of lymph nodes might
also be misclassified by FDG PET/CT. Although ethically and
technically challenging, a prospective study with histological
sampling to resolve discrepancies would further aid compari-
son between techniques. A second limitation of the study is
the generalisability of whole-body MRI quantitative features
across institutions. For example, absolute ADC values are
known to be dependent onMRI protocol parameters and scan-
ner platform [33, 34]. However our best-performing classifier
remained nodal size, and classification was not significantly
improved by ADC values. Third, we used the highest b value
of 500 s/mm2 for DWI disease assessment. We acknowledge
that a higher b value of 800–1,000 s/mm2 would have been in
line with current recommendations [35]; however the ADC
cut-off values were derived from previous work using a sim-
ilar DWI protocol to the current study [19]. Finally, whilst we
excluded nodes with short-axis diameter <5 mm from quanti-
tative analysis to minimise the partial voluming effect, partial
voluming effect on our quantitative measurements cannot be
entirely excluded.
Conclusion
We have demonstrated that both whole-body DWI and whole-
body STIR half-Fourier-acquisition single-shot turbo-spin-
echo MRI size measurements had similarly very good perfor-
mance for classifying nodal disease involvement in children
with known lymphoma. Combined short-axis diameter and
ADC thresholds marginally improve sensitivity and drop
specificity compared with size classification alone. We con-
tinue to advocate the use of anatomical criteria for nodal dis-
ease classification and raise caution over the interpretation of
ADC value as a classifier of disease, particularly in normal-
size (5- to 9-mm short-axis diameter) lymph nodes.
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